Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes
Clinical trial NCT02796170 · COMPLETED
Trial details
- NCT number
- NCT02796170
- Sponsor
- Tulane University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-08-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.